Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (3 quarters reported)
$738M in Q4 2025 → $747M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| EL Eli Lilly & Co | 6.3% | Added 89% | 39,086 | $46.9M |
| Pfizer Inc | 5.7% | Added 21% | 1,771,743 | $42.7M |
| VS Veeva Sys Inc | 5.6% | New | 236,709 | $42M |
| Biomarin Pharmaceutical Inc | 5.2% | New | 682,005 | $39M |
| Ptc Therapeutics Inc | 4.7% | Added 15% | 433,699 | $35.4M |
| BI Baxter Intl Inc | 4.2% | New | 1,459,380 | $31.1M |
| Insmed Inc | 4.0% | Added 45% | 281,838 | $30M |
| Zimmer Biomet Holdings Inc | 3.7% | Trimmed 45% | 317,426 | $27.3M |
| Insulet Corp | 3.6% | New | 176,932 | $26.9M |
| Thermo Fisher Scientific Inc | 3.5% | New | 51,934 | $26M |
| Abbott Laboratories | 3.5% | New | 285,778 | $25.9M |
| Ascendis Pharma A/s | 3.4% | New | 94,843 | $25.3M |
| Solventum Corp | 3.3% | New | 316,454 | $24.4M |
| Medtronic PLC | 3.2% | New | 303,301 | $23.7M |
| Elanco Animal Health Inc | 2.8% | Trimmed 7.2% | 864,080 | $21.3M |
| Agios Pharmaceuticals Inc | 2.7% | New | 546,848 | $20.3M |
| Envista Holdings Corporation | 2.6% | New | 726,108 | $19.1M |
| Revolution Medicines Inc | 2.1% | Trimmed 74% | 82,827 | $15.5M |
| IM Icu Med Inc | 2.1% | Trimmed 58% | 105,700 | $15.5M |
| Cogent Biosciences Inc | 2.0% | Added 12% | 393,441 | $15.2M |
| LH Lantheus Hldgs Inc | 2.0% | Trimmed 47% | 132,662 | $14.7M |
| Ocular Therapeutix Inc | 2.0% | Added 0.2% | 1,490,286 | $14.6M |
| Eledon Pharmaceuticals Inc | 1.9% | Trimmed 1.1% | 3,525,338 | $13.9M |
| Tyra Biosciences Inc | 1.6% | New | 376,870 | $12M |
| Olema Pharmaceuticals Inc | 1.5% | Trimmed 39% | 924,758 | $11.6M |
| Oric Pharmaceuticals Inc | 1.5% | Added 24% | 1,047,690 | $11.3M |
| Larimar Therapeutics Inc | 1.5% | New | 3,670,135 | $11.2M |
| GM Globus Med Inc | 1.5% | Trimmed 61% | 139,637 | $11M |
| Enovis Corporation | 1.5% | New | 531,945 | $11M |
| Evommune Inc | 1.4% | Added 17% | 793,145 | $10.5M |
| Teleflex Incorporated | 1.4% | New | 80,118 | $10.2M |
| Denali Therapeutics Inc | 1.3% | Trimmed 71% | 391,866 | $10.1M |
| Glaukos Corp | 1.2% | New | 66,519 | $9.3M |
| Staar Surgical Co | 1.2% | New | 322,126 | $9.24M |
| Pacs Group Inc | 1.2% | Trimmed 64% | 215,675 | $9.2M |
| CP Crinetics Pharmaceuticals In | 1.2% | New | 239,440 | $8.96M |
| Livanova PLC | 1.2% | New | 107,373 | $8.83M |
| BD Black Diamond Therapeutics I | 0.4% | New | 1,674,999 | $3.1M |
| Mereo Biopharma Group PLC | 0.3% | Unchanged | 7,558,756 | $2.4M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 2 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SH Schein Henry Inc | Exited | −624,037 | −$46M | — |
| BD Becton Dickinson & Co | Exited | −279,210 | −$43.9M | — |
| Revolution Medicines Inc | Trimmed | −233,145 | −$43.7M | 2.1% |
| VS Veeva Sys Inc | New | +236,709 | +$42M | 5.6% |
| Biomarin Pharmaceutical Inc | New | +682,005 | +$39M | 5.2% |
| Dexcom Inc | Exited | −538,762 | −$33.8M | — |
| Intuitive Surgical Inc | Exited | −67,681 | −$31.2M | — |
| BI Baxter Intl Inc | New | +1,459,380 | +$31.1M | 4.2% |
| Neurocrine Biosciences Inc | Exited | −209,932 | −$27.7M | — |
| Insulet Corp | New | +176,932 | +$26.9M | 3.6% |
Showing the 10 largest of 50 changes.
quarter ended March 31, 2026 · filed June 12, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Zimmer Biomet Holdings Inc | New | +579,161 | +$52.4M | 7.4% |
| Abbvie Inc | Exited | −227,669 | −$52M | — |
| Novartis Ag | Exited | −362,816 | −$50M | — |
| Steris PLC | Exited | −135,307 | −$34.3M | — |
| BD Becton Dickinson & Co | Added | +198,003 | +$31.1M | 6.2% |
| Neurocrine Biosciences Inc | New | +209,932 | +$27.7M | 3.9% |
| Ptc Therapeutics Inc | New | +376,165 | +$25.6M | 3.6% |
| Insmed Inc | Added | +144,909 | +$23.7M | 4.5% |
| SH Schein Henry Inc | Added | +303,615 | +$22.4M | 6.5% |
| Xencor Inc | Exited | −1,414,755 | −$21.7M | — |
Showing the 10 largest of 42 changes.
Loading...
